HYPERBARIC OXYGEN THERAPY FOR DIABETIC LEG ULCERS

Type 2 diabetes is almost imperceptible in its early stages, while it is a problem affecting most organs of the body. Diabetes mellitus has an adverse effect on the functioning of the heart, blood vessels, nerves, eyes and kidneys. If diabetes is maintained and kept within the normal range, the chance of developing complications associated with the disease is also reduced. Type 2 diabetes is almost imperceptible in its early stages, while it is a problem affecting most organs of the body. Diabetes mellitus has an adverse effect on the functioning of the heart, blood vessels, nerves, eyes and kidneys. If diabetes is maintained and kept within the normal range, the chance of developing complications associated with the disease is also reduced.

HOW DOES HYPERBARIC OXYGEN THERAPY HELP CURE LEG ULCERS?

Based on our experience so far and international publications, hyperbaric oxygen therapy is effective in the treatment of diabetic leg ulcers, even just before amputation, there is a chance to save the limb.
Hyperbaric oxygen therapy in a high-pressure chamber uses 98% pure oxygen inhalation to initiate physiological processes that cause faster healing of wounds. Such as, for example, the acceleration of capillary formation, the increase in the blood supply of narrowed, blocked blood vessels. The increased amount of oxygen in the bloodstream also increases resistance to bacteria, thus preventing further infection and growth of wounds.

The beneficial effect of hyperbaric oxygen therapy is effective in reducing diabetic wounds even after a few sessions. This is confirmed by the case of Otto K., who has been suffering from diabetes for many years. Recently, he noticed the appearance of small wounds on his shins. Her mother used to have a similar start with leg ulcers, so she knew she needed to start treating the wounds in time. As a result of hyperbaric oxygen therapy, small wounds completely disappeared already after the eighth session.

One of these complications is leg ulcers, which in many cases can end in amputation. The positive effect of hyperbaric oxygen therapy on difficult-to-heal wounds may even prevent limb removal.
The main feature of leg ulcers is that they heal more slowly than an average wound, often taking months to resolve. Due to the long healing process, bacteria can multiply rapidly in the wound and their surface area increases due to continuous infection

Diabetes mellitus has a detrimental effect on blood vessels, so blood vessels cannot develop, the formation of capillaries slows down. Due to the damage to nerves in the foot, most patients feel less and less with their feet, so even a kick to the threshold can easily lead to amputation.

PREVENT THE DEVELOPMENT OF COMPLICATIONS OF DIABETES!

Prevent the spread of diabetic wounds!

Book an appointment now and take action for your health!

Fee of treatment: USD 100.-/ person/ occasion.

BOOK AN APPOINTMENT!

RESEARCH

There is currently a lot of research going on about the potential benefits of hyperbaric oxygen therapy for controlling atherosclerosis and blood sugar levels in patients with diabetic leg ulcers.

One study tested the effects of hyperbaric oxygen therapy (HBOT) on atherosclerosis, inflammatory markers and other clinical and laboratory parameters in patients undergoing HBOT treatment for diabetic foot ulcers.

28 patients with diabetic leg ulcers were enrolled. All patients received 100% oxygen at 2.4 absolute atmospheres (ATA) for approximately 105 minutes, five times per week, for a total of 30 times. Fasting blood glucose (FBG), hemoglobin A1c (HbA1c), homeostasis model measurement – insulin resistance (HOMA-IR), high sensitivity C-reactive protein (hs-CRP), uric acid, mean platelet volume (MPV), complete blood count and lipid profile were tested.

Results: At treatment end, a statistically significant improvement was observed in the mean values of all parameters evaluated. HBOT has also been shown to have beneficial effects on atherosclerosis and glycemic control in diabetics.
(Source: https://pubmed.ncbi.nlm.nih.gov/20602302/)